Last reviewed · How we verify
EBV TCR-T
At a glance
| Generic name | EBV TCR-T |
|---|---|
| Sponsor | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EBV TCR-T CI brief — competitive landscape report
- EBV TCR-T updates RSS · CI watch RSS
- Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine portfolio CI